Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology News Journal.
Press releases published on June 25, 2025

Summer's Impact on the Blood Supply
Davenport, Iowa, June 25, 2025 (GLOBE NEWSWIRE) -- ImpactLife is seeing the effect of summer vacation season on our region’s blood supply, and with the Fourth of July weekend just ahead, the blood center is now looking to add appointments and improve the …

Altin Biosciences announces US patent approval for its first-in-class, non-hormonal, oral botanical drug candidate.
A non-surgical, non-hormonal drug that is easy to take, easy to tolerate, and preserves fertility is exactly what patients and doctors have demanded for years. EMERYVILLE, CA, UNITED STATES, June 25, 2025 /EINPresswire.com/ -- Non-hormonal oral …

2025 latest cloud mining solution: FansHash cloud mining supports Bitcoin (BTC), Dogecoin (DOGE), Monero (XMR) and more than 10 currencies.
London, United Kingdom, June 25, 2025 (GLOBE NEWSWIRE) -- Fans Hash, the world's leading cloud mining service provider, today officially released its new cloud mining solution for 2025, supporting the mining of more than 10 mainstream digital currencies …

ABeam Consulting (USA) Ltd. and Millennium EBS Establish Strategic Collaborations to Expedite ISO 20022 Implementation
LOS ANGELES, June 25, 2025 (GLOBE NEWSWIRE) -- ABeam Consulting (USA) Ltd. (“ABeam US”) and Millennium EBS, a BlueOne Card Inc. subsidiary, have announced a strategic collaboration under a newly signed Master Services Agreement (MSA) to jointly promote the …

Wesdome Provides Kiena Exploration Update; Reports High-Grade Mineralization Including 2,349.9 g/t Gold (Uncut) Over 2.9 Metres (Core Length)
TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- Wesdome Gold Mines Ltd. (TSX:WDO, OTCQX:WDOFF) (“Wesdome” or the “Company”) today provides a comprehensive update on its underground exploration activities at its wholly-owned Kiena mine (“Kiena”) in Val-d’Or, …

PSYENCE GROUP INC. Announces Update on Previously Announced Non-Brokered Private Placement of Common Shares
TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its …

Clip Money Inc. Announces Results of Voting at Annual Meeting of Shareholders
TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- Clip Money Inc. (TSX-V: CLIP) (OTCQB: CLPMF) (“Clip Money” or the “Company”), a company that operates a multi-bank self-service deposit system for businesses, is pleased to announce the results of voting at its …

Vor Bio Announces $175 Million Private Placement
CAMBRIDGE, Mass., June 25, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it has entered into a securities purchase agreement for a private …

Data Squared (Data²) Secures Patent for Hallucination-Resistant, Explainable AI Systems
BELLEVUE, Wash., June 25, 2025 (GLOBE NEWSWIRE) -- Data Squared (Data²), a Service-Disabled Veteran-Owned Small Business dedicated to helping public and private sector organizations unlock the full potential of their data, today announced that the U.S. …

Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset
-Vor Bio receives ex-Greater China rights to develop and commercialize telitacicept, a novel, dual-target recombinant fusion protein in global Phase 3 development for generalized myasthenia gravis -RemeGen receives initial payment of $125 million …

Main Results of 2025 Annual and Extraordinary General Meeting
REYKJAVÍK, Iceland and LUXEMBOURG, June 25, 2025 (GLOBE NEWSWIRE) -- The 2025 Annual and Extraordinary General Meeting (the "2025 AGM") of Alvotech (the "Company") was held on June 25, 2025, at Arendt House, 41A Avenue John F. Kennedy, L-2082 Luxembourg, …

Coalition to Improve Access to Cancer Care Applauds Reintroduction of the Cancer Drug Parity Act
WASHINGTON, June 25, 2025 (GLOBE NEWSWIRE) -- The Coalition to Improve Access to Cancer Care (CIACC) applauds the reintroduction of the Cancer Drug Parity Act, bipartisan legislation that would require group and individual health insurance plans to cover …

BIGtoken Welcomes Pro Soccer and Sports Industry Leaders Aly Wagner and Adam Eyre as Strategic Investors and Advisors
NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- BIGtoken, the Web3 marketing platform helping organizations turn real-world audiences into owned, monetizable data, today announced a strategic partnership with soccer industry veterans Aly Wagner and Adam Eyre. …

Teva to Host Conference Call to Discuss Second Quarter 2025 Financial Results at 8 a.m. ET on July 30, 2025
TEL AVIV, Israel, June 25, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter 2025 financial results on Wednesday, July 30, 2025, at 7:00 a.m. ET. …

Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering
CUPERTINO, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central …

Golar LNG Limited Announces Proposed Offering of $500 Million of Convertible Senior Notes due 2030
Hamilton, Bermuda, June 25, 2025 – Golar LNG Limited (the “Company”) (NASDAQ: GLNG) announces today that it intends to offer, subject to market and other conditions, $500 million aggregate principal amount of Convertible Senior Notes due 2030 (the “Notes”) …

DBV Technologies annonce le screening du premier sujet de l'étude complémentaire d’innocuité COMFORT Toddlers chez les enfants âgés de 1 à 3 ans allergiques à l’arachide.
Châtillon, France, le 25 juin (22 :30 CEST) 2025 DBV Technologies annonce le screening du premier sujet de l'étude complémentaire d’innocuité COMFORT Toddlers chez les enfants âgés de 1 à 3 ans allergiques à l’arachide. Screening du premier sujet à l' …

DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old
Châtillon, France, June 25, 2025 DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old First subject screened at the Respiratory Medicine Research Institute of Michigan …

NevGold Releases Some of the Highest Grade Oxide Gold-Antimony Results To Date: 9.68 g/t AuEq Over 11.6 Meters (8.92 g/t Au And 0.17% Antimony) Within 2.85 g/t AuEq Over 60.3 Meters (2.27 g/t Au And 0.13% Antimony) at the Limousine Butte Project, Nevada
Vancouver, British Columbia , June 25, 2025 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce further significant oxide gold-antimony (“Antimony”, “Sb”) drill results at its …

Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, June 26, 2025 at 9:00 A.M. ET
HOUSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, …